Advances in Endoscopic Eradication Therapy for Barrett’s Esophagus associated neoplasia have resulted in a significant paradigm shift in diagnosis and management of this complex disease. A robust body of literature critically evaluating outcomes of resection and ablative strategies has allowed gastroenterologists to make quality, evidence based decisions for their patients. Despite this progress, there are still many unanswered questions and challenges that remain. Ultimately, identification of a cost-effective screening modality, biomarkers for risk stratification, and strides to eliminate post surveillance endoscopy after EET are essential to reach our long term goal for eradication of esophageal adenocarcinoma.

Barrett食管相关肿瘤的内镜根除疗法的进展已导致这种复杂疾病的诊断和治疗发生了重大变化。大量的文献对手术切除和消融策略的结果进行了严格的评估，从而使肠胃科医生能够为患者做出高质量，循证的决策。尽管取得了这一进展，但仍然存在许多悬而未决的问题和挑战。最终，对于实现我们根除食管腺癌的长期目标而言，鉴定具有成本效益的筛查方式，进行风险分层的生物标志物以及消除EET后的监测后内镜检查的进步对于实现我们根除食管腺癌的长期目标至关重要。